Athenex, Inc. (ATNX): Price and Financial Metrics
ATNX Price/Volume Stats
| Current price | $0.20 | 52-week high | $23.80 |
| Prev. close | $0.27 | 52-week low | $0.20 |
| Day low | $0.20 | Volume | 1,880,200 |
| Day high | $0.26 | Avg. volume | 194,316 |
| 50-day MA | $1.15 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 1.76M |
ATNX Stock Price Chart Interactive Chart >
Athenex, Inc. (ATNX) Company Bio
Athenex Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. The company was founded in 2003 and is based in Buffalo, New York.
ATNX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -67.60% |
| 5-year | -98.24% |
| YTD | N/A |
| 2024 | N/A |
| 2023 | 0.00% |
| 2022 | -89.15% |
| 2021 | -87.70% |
| 2020 | -27.57% |
Continue Researching ATNX
Want to do more research on Athenex Inc's stock and its price? Try the links below:Athenex Inc (ATNX) Stock Price | Nasdaq
Athenex Inc (ATNX) Stock Quote, History and News - Yahoo Finance
Athenex Inc (ATNX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...